MedTrace Logo

Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)

NCT06259175 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 396

Last updated 2025-06-11

No results posted yet for this study

Summary

This is a multi-centre, observational, ambispective study, which will retrospectively and prospectively collect clinical and socio-demographic data from medical records of outpatients with arterial hypertension (HTN) initiated with the amlodipine/indapamide/perindopril SPC in real clinical settings.

375 patients to be included in the study in order for at least 300 patients to complete the study and provide an estimated 90% power of the study.

75 outpatient general practitioners and cardiologists will participate in this study.

Conditions

  • Arterial Hypertension
  • HTN

Interventions

DRUG

Amlodipine 5 mg + indapamide 1.25 mg + perindopril 5 mg

a triple fixed combination of Amlodipine , indapamide and perindopril combinations, was in a 3-month in accordance to the instruction for medical use approved in the Russian Federation

DRUG

Amlodipine 5 mg + indapamide 2.5 mg + perindopril 10 mg

a triple fixed combination of Amlodipine , indapamide and perindopril combinations, was in a 3-month in accordance to the instruction for medical use approved in the Russian Federation

DRUG

Amlodipine 10 mg + indapamide 2.5 mg + perindopril 10 mg

a triple fixed combination of Amlodipine , indapamide and perindopril combinations, was in a 3-month in accordance to the instruction for medical use approved in the Russian Federation

Sponsors & Collaborators

  • Servier Russia

    lead INDUSTRY

Principal Investigators

  • Alexandra Konradi · Medical Education Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2025-04-21
Completion
2025-06-01

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06259175 on ClinicalTrials.gov